PRINCIPIA BIOPHARMA
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
PRINCIPIA BIOPHARMA
Industry:
Biopharma Biotechnology Life Science
Founded:
2008-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.principiabio.com
Total Employee:
11+
Status:
Closed
Contact:
(650) 416-7700
Email Addresses:
[email protected]
Total Funding:
127.8 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Apache 2.4 Amazon SSL Gravity Forms Mimecast
Similar Organizations
Algaeon
Algaeon supplies high-value products derived from algae to companies in the human nutraceutical and fish feed industries.
Artizan Biosciences
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Echo
Echo is a provider of an automated microscope intended for biological research and pathologies.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
FoxBio
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
Olipass
OliPass Corporation is committed to revolutionize our views of life sciences and bring us great quality of life.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Mission BioCapital
Mission BioCapital investment in Venture Round - Principia Biopharma
SR One
SR One investment in Series B - Principia Biopharma
Sofinnova Investments
Sofinnova Investments investment in Series B - Principia Biopharma
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Principia Biopharma
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Principia Biopharma
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Principia Biopharma
OrbiMed
OrbiMed investment in Series B - Principia Biopharma
SR One
SR One investment in Series B - Principia Biopharma
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Principia Biopharma
Sofinnova Investments
Sofinnova Investments investment in Series B - Principia Biopharma
Official Site Inspections
http://www.principiabio.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
